VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for ...

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...

SOUTH BEND, Ind. -- Beck's Lake at LaSalle Park was used as an illegal dumping ground from the 1930s to the 1950s, leaving behind toxins in the soil such as lead and arsenic. The Environmental ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.